No Data
No Data
Palisade Bio CEO Finley's Revised Employment and Compensation Deal
Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis
Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies
Express News | Palisade Bio Inc - Phase 1 Study of Pali-2108 for Uc to Commence Before Year-End
Express News | Palisade Bio Reports Data Demonstrating Pde4B Expression in Patient Cohorts Could Be Utilized as a Potential Marker for Patient Stratification
Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could Be Utilized as a Potential Marker for Patient Stratification
No Data
No Data